Back to Screener

Healthcare

Neonc Technologies Holdings, Inc.(NTHI)

Live Price

Offline

$5.27

+9.56% today

1Y Change

+32.08%

Window

Jun 26, 2025 โ†’ Jun 18, 2026

Market Cap
$80.00M
Revenue Growth
0.0%
EPS Growth
0.0%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 26, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Neonc Technologies Holdings, Inc. (NTHI) is a Healthcare stock with a market cap of $80.00M and listed on NASDAQ. The stock last traded around $5.27 and up 32.1% across the available one-year price window (Jun 26, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin -159831.0% and ROIC 571.0%. Valuation already assumes a fairly strong business story at price/sales 2030.0. Stock Foundry combines NTHI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

NTHI vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

NTHI

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

NTHI Max Drawdown

-66.42%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for NTHI and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Neonc Technologies Holdings, Inc. (NTHI)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$40.0K

FY Net Income

-$62.1M

Free Cash Flow

-$20.9M

Revenue Growth

+0.0%

EPS Growth

+0.0%

Gross Margin

100.0%

Net Margin

-169597.9%

Income statement

USD

Annual
Metric2025
Revenue40K
Gross Profit40K
Operating Income-58M
EBITDA-60M
Net Income-62M
EPS (Diluted)โ€”

Balance sheet

USD

Point-in-time
Metric2025
Cash & Equivalents59K
Total Assets3M
Total Liabilities20M
Shareholder Equity-18M
Total Debt6M
Net Debt6M

Cash flow positioning

Latest Full Year

Operating Cash Flow

20M

Capital Expenditures

500K

Free Cash Flow

21M

Key ratios

  • Gross Margin

    100.0%

  • Operating Margin

    -159831.0%

  • Net Margin

    -169597.9%

  • ROE

    534.4%

  • Debt / Equity

    -0.36x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.